Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Corbella

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Clinical and Experimental Rheumatology|February 24, 2017
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)Manuel Rubio-Rivas, Carmen Pilar Simeón-Aznar, César Velasco, et al.
Journal of Clinical Medicine|April 3, 2021
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA StudyBárbara Fernández-Cidón, Beatriz Candás-Estébanez, Miriam Gil-Serret, et al.
Frontiers in Medicine|July 1, 2021
Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled TrialXavier Solanich, Arnau Antolí, Gemma Rocamora-Blanch, et al.
Frontiers in Immunology|August 9, 2021
Genetic Screening for <i>TLR7</i> Variants in Young and Previously Healthy Men With Severe COVID-19Xavier Solanich, Gardenia Vargas-Parra, Caspar I van der Made, et al.
The Journal of Rheumatology|February 17, 2019
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry StudyMelani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, et al.
Revista Espanola De Cardiologia (English Ed.)|March 24, 2023
Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settingsCristina Capdevila Aguilera, Emili Vela Vallespín, Montse Clèries Escayola, et al.
Journal of Clinical Immunology|September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in BarcelonaXavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
Clinical Rheumatology|June 23, 2018
Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort studyManuel Rubio-Rivas, Xavier Corbella, Melany Pestaña-Fernández, et al.
Journal of Clinical Medicine|November 3, 2020
Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19Manuel Rubio-Rivas, Xavier Corbella, José María Mora-Luján, et al.
Journal of Clinical Medicine|June 2, 2021
Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 RegistryManuel Rubio-Rivas, Xavier Corbella, Francesc Formiga, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Rheumatology|February 24, 2017
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)Manuel Rubio-Rivas, Carmen Pilar Simeón-Aznar, César Velasco, et al.
Journal of Clinical Medicine|April 3, 2021
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA StudyBárbara Fernández-Cidón, Beatriz Candás-Estébanez, Miriam Gil-Serret, et al.
Frontiers in Medicine|July 1, 2021
Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled TrialXavier Solanich, Arnau Antolí, Gemma Rocamora-Blanch, et al.
Frontiers in Immunology|August 9, 2021
Genetic Screening for <i>TLR7</i> Variants in Young and Previously Healthy Men With Severe COVID-19Xavier Solanich, Gardenia Vargas-Parra, Caspar I van der Made, et al.
The Journal of Rheumatology|February 17, 2019
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry StudyMelani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, et al.
Revista Espanola De Cardiologia (English Ed.)|March 24, 2023
Population-based evaluation of the impact of socioeconomic status on clinical outcomes in patients with heart failure in integrated care settingsCristina Capdevila Aguilera, Emili Vela Vallespín, Montse Clèries Escayola, et al.
Journal of Clinical Immunology|September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in BarcelonaXavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
Clinical Rheumatology|June 23, 2018
Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort studyManuel Rubio-Rivas, Xavier Corbella, Melany Pestaña-Fernández, et al.
Journal of Clinical Medicine|November 3, 2020
Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19Manuel Rubio-Rivas, Xavier Corbella, José María Mora-Luján, et al.
Journal of Clinical Medicine|June 2, 2021
Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 RegistryManuel Rubio-Rivas, Xavier Corbella, Francesc Formiga, et al.
Pageof 10